Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Cancer Research

• Publication date

  1998-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9485010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.

  1997cited by this paper
• Clinical implications of telomerase in cancer.

  1997cited by this paper
• Telomerase activity in primary prostate cancer.

  1997cited by this paper
• Telomerase catalytic subunit homologs from fission yeast and human.

  1997cited by this paper
• Telomerase Catalytic Subunit Homologs from Fission Yeast and Human

  1997cited by this paper
• Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression

  1997cited by this paper
• A survey of telomerase activity in human cancer.

  1997cited by this paper
• REVIEW ARTICLE. TELOMERES AND DISEASE

  1996cited by this paper
• Biomarker expression in prostatic intraepithelial neoplasia.

  1996cited by this paper
• Telomerase activity in human breast tumors.

  1996cited by this paper
• Telomerase activity: a prevalent marker of malignant human prostate tissue.

  1996cited by this paper
• Telomerase activity associated with acquisition of malignancy in human colorectal cancer.

  1995cited by this paper
• Telomeres, telomerase, and immortality.

  1995cited by this paper
• Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.

  1995cited by this paper
• Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity.

  1995cited by this paper
• Specific association of human telomerase activity with immortal cells and cancer.

  1994cited by this paper
• Prostate cancer kills: strategy to reduce deaths.

  1994cited by this paper
• The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients.

  1993cited by this paper
• Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

  1992cited by this paper
• Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens.

  1989cited by this paper
• Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

  1979cited by this paper
• Isolation of a human prostate carcinoma cell line (DU 145)

  1978cited by this paper

• Promoter hypermethylation drives a paradoxical up regulation of hTERT with prognostic implications in bladder cancer.

  2025cites this paper
• Changes in TP53 Gene, Telomere Length, and Mitochondrial DNA in Benign Prostatic Hyperplasia Patients

  2024cites this paper
• Changes in TP53 gene, telomere length, mitochondrial DNA, and its amount in benign prostatic hyperplasia patients

  2024cites this paper
• Race Differences in Telomere length in benign prostate biopsies and subsequent risk of prostate cancer.

  2022cites this paper
• Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer

  2022cites this paper
• The telomere length landscape of prostate cancer

  2021cites this paper
• Benign prostatic hyperplasia – what do we know?

  2020cites this paper
• Identification of glycosylations affected by androgen-regulated process on the surface of extracellular vesicles derived from PCa cell lines

  2019cites this paper
• Genetics in the Prostate Cancer Genetics in the Prostate Cancer

  2018cites this paper
• Genetics in the Prostate Cancer

  2018cites this paper
• MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer

  2018influential citation
• Identification of signalling pathways involved in the oxidative stress response triggered by Low Temperature Plasma in prostate epithelial cells and the assessment of tumour-associated allelic expression in prostate cancer

  2018cites this paper
• Telomeres and telomerase in prostate cancer development and therapy

  2017cites this paper
• Targeting strategies of adenovirus-mediated gene therapy and virotherapy for prostate cancer

  2017cites this paper
• A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study

  2016cites this paper
• Identification and validation of novel prostate cancer biomarkers

  2016cites this paper
• Widespread telomere instability in prostatic lesions

  2016cites this paper
• The molecular and cellular origin of human prostate cancer.

  2016cites this paper
• Designed modulation of sex steroid signaling inhibits telomerase activity and proliferation of human prostate cancer cells.

  2014cites this paper
• GENETICS AND MOLECULAR ASPECTS OF PROSTATE CANCER: REVIEW

  2014cites this paper
• MNS16A tandem repeat minisatellite of human telomerase gene and prostate cancer susceptibility.

  2013influential citation
• Chapter 8 A Glance at the Complexity of Nutrition and the Prostate : Considering Molecular Targets to Unravel the Most Recent Controversy Between Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk

  2013cites this paper
• A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers

  2013cites this paper
• Differences in the expression of telomerase and prostate-specific membrane antigen in non-advanced prostatic cancer.

  2013cites this paper
• A Glance at the Complexity of Nutrition and the Prostate: Considering Molecular Targets to Unravel the Most Recent Controversy Between Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk

  2013cites this paper
• Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases.

  2012cites this paper
• Molecular Genetics and Cancer Biology

  2012cites this paper
• Control of gene expression in prostate epithelial cell differentiation hierarchy

  2012cites this paper
• Telomerase as an Androgen Receptor-Regulated Target in Selenium Chemoprevention of Prostate Cancer

  2011cites this paper
• Identification of new urine biomarkers for the detection of prostate cancer

  2011cites this paper
• Molecular regulation of telomerase activity in aging

  2011cites this paper
• Nukleäre p53-Akkumulation und Marker der genetischen Instabilität beim Prostatakarzinom

  2011cites this paper
• Pre-malignant Disease in the Prostate

  2011cites this paper
• The effects of telomerase inhibition on prostate tumor‐initiating cells

  2010cites this paper
• Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer

  2010cites this paper
• The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer.

  2010influential citation
• Telomerase as an Important Target of Androgen Signaling Blockade for Prostate Cancer Treatment

  2010cites this paper
• Dietary Chemoprevention Studies in Preclinical Models of Prostate Cancer: Bioactive Lipids and Vitamin D

  2010cites this paper
• MYC and Prostate Cancer.

  2010cites this paper
• Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.

  2009cites this paper
• Diagnostic Value I: Solid Tumors

  2009cites this paper
• Causes and consequences of genomic instability in prostatic carcinogenesis.

  2009cites this paper
• Expression profile and prognostic importance in prostate lesions of the reverse transcriptase component of human telomerase (hTERT) and of cyclin-dependent kinase

  2009cites this paper
• Prostate tumor-initiating cells: a new target for telomerase inhibition therapy?

  2009cites this paper
• Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments.

  2009cites this paper
• Expression profile and prognostic importance in prostate lesions of the reverse transcriptase component of human telomerase (hTERT) and of cyclin-dependent kinase inhibitor p57 (p57kip2a)

  2009cites this paper
• Telomerase activity (TMA) in tumour and peritumoural tissues in a rat liver cancer model.

  2009cites this paper
• Análise da expressão dos genes STEAP1 e STEAP2 em adenocarcinomas de próstata por RT-PCR quantitativa em tempo real

  2008cites this paper
• Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas.

  2008cites this paper
• Putative tissue markers in prostate cancer*.

  2008cites this paper
• Wild‐type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development

  2008cites this paper
• Prostatic preneoplasia and beyond.

  2008cites this paper
• Putative tissue markers in prostate cancer *

  2008cites this paper
• Prostate cancer: Re-focusing on androgen receptor signaling.

  2007cites this paper
• Is repeat biopsy for isolated high-grade prostatic intraepithelial neoplasia necessary?

  2007cites this paper
• Molecular genetics of prostate cancer: clinical translational opportunities.

  2007cites this paper
• Telomerase Activity in Tumor and Remnant Liver as Predictor of Recurrence and Survival in Hepatocellular Carcinoma after Resection

  2007cites this paper
• Telomere attrition in isolated high-grade prostatic intraepithelial neoplasia and surrounding stroma is predictive of prostate cancer.

  2007cites this paper
• Telomeres, Telomerase, Chromosome Stability, and Prostate Cancer

  2007cites this paper
• The role of telomeres and telomerase in the pathology of human cancer and aging

  2006cites this paper
• Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.

  2006cites this paper
• High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.

  2006cites this paper
• Small molecule, oligonucleotide-based telomerase template inhibition in combination with cytolytic therapy in an in vitro androgen-independent prostate cancer model.

  2006cites this paper
• Novel Biomarkers for Disease Diagnosis, Prognosis, and Prediction

  2006cites this paper
• Molecular genetic predictors of prostate cancer progression after radical prostatectomy.

  2006cites this paper
• Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology.

  2006cites this paper
• Neosis—a paradigm of self‐renewal in cancer

  2005influential citation
• Immortalization of primary human prostate epithelial cells by c-Myc.

  2005cites this paper
• Nuclear hTERT immunohistochemical expression is associated with survival of patients with urothelial bladder cancer.

  2005cites this paper
• New Insights in Telomerase and Telomeric Proteins and Their Clinical Application to Urological Cancers

  2005cites this paper
• Noninvasive Detection of Prostate Cancer by Quantitative Analysis of Telomerase Activity

  2005cites this paper
• Treatment of Carcinogenesis

  2004cites this paper
• Age-dependent methylation of ESR1 gene in prostate cancer.

  2004cites this paper
• Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia

  2004cites this paper
• Mutational analysis of PINX1 in hereditary prostate cancer

  2004cites this paper
• Telomerase and Cancer

  2004cites this paper
• Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?

  2004cites this paper
• Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT

  2004cites this paper
• Basic principles of cancer cell culture.

  2004cites this paper
• Immortalization of human prostate cells with the human papillomavirus type 16 E6 gene.

  2004cites this paper
• Detection of Prostate Cancer and Predicting Progression

  2004cites this paper
• Chapter 11 – Genetic Changes and Their Prognostic Significance in Prostate Cancer

  2003cites this paper
• Oncogenes and Tumour Suppressor Genes in Prostate Cancer

  2003cites this paper
• Telomerase Activity and Telomerase Subunit Gene Expression Levels Are Not Related in Prostate Cancer: A Real-Time Quantification and In Situ Hybridization Study

  2003cites this paper
• High‐throughput analysis of telomerase by capillary electrophoresis

  2003cites this paper
• Expression‐patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer

  2003influential citation
• Prostatic androgen repressed message‐1 (PARM‐1) may play a role in prostatic cell immortalisation

  2003cites this paper
• Telomerase expression as a marker in prostate cancer: correlation to clinicopathologic predictors.

  2003cites this paper
• Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy?

  2002cites this paper
• DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.

  2002cites this paper
• Molecular staging of pelvic surgical margins after radical prostatectomy: comparison of RT-PCR for prostate-specific antigen and telomerase activity.

  2002cites this paper
• Telomerase reverse transcriptase subunit immunoreactivity

  2002cites this paper
• Evaluation of PCR-ELISA for determination of telomerase activity in prostate needle biopsy and prostatic fluid specimens.

  2002cites this paper
• Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation.

  2002cites this paper
• 4 In situ hybridization of human telomerase reverse transcriptase mRNA in prostate carcinoma

  2002cites this paper
• Signaling through estrogen receptors modulates telomerase activity in human prostate cancer.

  2002cites this paper
• Renal Cancer: Methods and Protocols

  2001cites this paper
• Telomerase in endocrine and endocrine-dependent tumors.

  2001cites this paper
• Molecular changes associated with prostate cancer development.

  2001cites this paper
• Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT).

  2001cites this paper